G. M. Bartelds

Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up

G. M. Bartelds · JAMA · 2011 · 767 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

G. M. Bartelds, Carla A. Wijbrandts, Michael T. Nurmohamed et al. · Annals of the Rheumatic Diseases · 2007 · 567 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study

G. M. Bartelds, Carla A. Wijbrandts, Michael T. Nurmohamed et al. · Annals of the Rheumatic Diseases · 2009 · 223 citations · Full text

Life Sciences, Immunology, Internal Medicine +16

The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept

Anna Jamnitski, G. M. Bartelds, Michael T. Nurmohamed et al. · Annals of the Rheumatic Diseases · 2010 · 178 citations

Life Sciences, Immunology, Pharmacotherapy +17

A novel method for the detection of antibodies to adalimumab in the presence of drug reveals “hidden” immunogenicity in rheumatoid arthritis patients

Pauline A. van Schouwenburg, G. M. Bartelds, M. Hart et al. · Journal of Immunological Methods · 2010 · 160 citations

Life Sciences, Clinical Sciences, Immunology +17